JNJ multiple myeloma therapy outperforms standard of care by 58%
https://seekingalpha.com/news/4045689-jnj-multiple-myeloma-therapy-outperforms-standard-of-care?source=feed_sector_healthcare
Dec 12, 2023 - Johnson & Johnson's (JNJ) multiple myeloma therapy Darzalex Faspro in combination with traditional treatments outperforms standard of care. Read more here.
0
JNJ looking to move talc powder unit to Texas ahead of bankruptcy filing: report
https://seekingalpha.com/news/4056938-jnj-looking-to-move-talc-powder-unit-to-texas-ahead-of-bankruptcy-filing-report?source=feed_sector_healthcare
Jan 22, 2024 - Johnson & Johnson (JNJ) is reportedly looking to relocate its LTL talc powder unit to Texas ahead of an expected third bankruptcy filing for the subsidiary. Read more here.
0
Johnson & Johnson (JNJ) Q4 2023 Earnings Call Transcript
https://www.fool.com/earnings/call-transcripts/2024/01/23/johnson-johnson-jnj-q4-2023-earnings-call-transcri/?source=iedfolrf0000001
Jan 23, 2024 - JNJ earnings call for the period ending December 31, 2023.
0
7 Dividend Stocks That Pay Me More Than $500 Per Month
https://www.fool.com/investing/2024/02/03/7-dividend-stocks-that-pay-me-more-than-500-per-mo/?source=iedfolrf0000001
Feb 03, 2024 - These stocks pay safe, reliable, and growing dividends.
0
Can a New CEO Fix Boeing?
https://www.fool.com/investing/2024/04/06/can-a-new-ceo-fix-boeing/?source=iedfolrf0000001
Apr 06, 2024 - We also talk with e.l.f. Beauty CEO Tarang Amin about how the company is succeeding.
0
JNJ Q1 earnings preview: A lot of moving factors expected to bring in-line results
https://seekingalpha.com/news/4089736-jnj-q1-earnings-preview-a-lot-of-moving-factors-expected-to-bring-in-line-results?source=feed_sector_healthcare
Apr 15, 2024 - Johnson & Johnson (JNJ) is set to announce Q1 earnings results, and analysts expect a profit of $2.65 (-1.1% Y/Y) on revenue of $21.39B (-13.4% Y/Y).
0
Can JNJ reverse loss in 2024 on EPS growth, eyes on talc litigation
https://seekingalpha.com/news/4050710-can-jnj-reverse-loss-in-2024-on-eps-growth-eyes-on-talc-litigation?source=feed_sector_healthcare
Dec 27, 2023 - Johnson & Johnson 2024: What to Expect Wells Fargo downgraded Johnson & Johnson (JNJ) to equal weight and lowered PT to $163 from $170 as analyst expects EPS gr
0
There Are Only 5 Dow Stocks I Wouldn't Buy in 2024
https://www.fool.com/investing/2023/12/29/there-are-only-5-dow-stocks-i-wouldnt-buy-in-2024/?source=iedfolrf0000001
Dec 29, 2023 - There's a lot to like about Apple, Microsoft, and most of the Dow Jones Industrial Average components in 2024.
0
2 Best Warren Buffett Stocks to Buy for the Long Haul
https://www.fool.com/investing/2023/12/30/2-best-warren-buffett-stocks-to-buy-for-the-long/?source=iedfolrf0000001
Dec 30, 2023 - These companies need no introduction.
0
3 Unstoppable Dividend Stocks That Could Pay You for Life
https://www.fool.com/investing/2024/02/17/3-unstoppable-dividend-stocks-that-could-pay-you-f/?source=iedfolrf0000001
Feb 17, 2024 - There are no certainties in life or on the stock market. These companies' dividends are about as close as we can get.
0
Page 1>